BCL-2 Inhibition at Antiretroviral Therapy Start Shrinks Intact SIV Reservoir
Targeting the BCL-2 cell-survival pathway at the start of antiretroviral therapy reduced the pool of intact SIV proviruses in macaques, ...
Targeting the BCL-2 cell-survival pathway at the start of antiretroviral therapy reduced the pool of intact SIV proviruses in macaques, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine